metformin has been researched along with Erythrocytosis in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This self-controlled case series study aims to evaluate whether metformin use and SGLT2i-associated erythrocytosis influence its cardiovascular benefits." | 8.12 | Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study. ( Au, ICH; Lau, KTK; Lee, CH; Lee, CYY; Lui, DTW; Tan, KCB; Tang, EHM; Wong, CKH; Woo, YC, 2022) |
| " This self-controlled case series study aims to evaluate whether metformin use and SGLT2i-associated erythrocytosis influence its cardiovascular benefits." | 4.12 | Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study. ( Au, ICH; Lau, KTK; Lee, CH; Lee, CYY; Lui, DTW; Tan, KCB; Tang, EHM; Wong, CKH; Woo, YC, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wong, CKH | 1 |
| Lau, KTK | 1 |
| Tang, EHM | 1 |
| Lee, CH | 1 |
| Lee, CYY | 1 |
| Woo, YC | 1 |
| Au, ICH | 1 |
| Tan, KCB | 1 |
| Lui, DTW | 1 |
1 other study available for metformin and Erythrocytosis
| Article | Year |
|---|---|
Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Heart Failure; Humans; Metformin; Polycythemia; | 2022 |